Gut microbiome: meet Ruminococcus gnavus – the bacteria with a sweet tooth

Estimated reading time: 6 minutes

Nathalie Juge, Quadram Institute

Ruminococcus gnavus (R gnavus for short) is one of the many bacterial species normally found in the human gut. While it doesn’t typically cause us harm, a growing body of evidence indicates that an overgrowth of R gnavus may be linked with certain intestinal diseases – including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and colon cancer.

Not only that, but research has also found that people with health problems affecting other parts of the body – including skin allergies, heart disease, stroke, liver disease and brain disorders – have higher levels of these bacteria in their gut.

This association does not necessarily mean that R gnavus is a cause of these diseases. Rather, it may simply indicate that these diseases create favourable conditions for R gnavus to grow in the gut. Researchers are currently working to find the answer to this question, so that we better understand how R gnavus influences health and disease. This may also help us find new ways of diagnosing and treating certain diseases.

Sweet tooth

Not all R gnavus strains are equal. As with other bacteria, the name covers a multitude of strains with different characteristics, which may drive different health outcomes.

Some strains live in the lining of our gut and are therefore well positioned to sense changes in the gut environment and communicate them with the rest of the body. These play a role in our underlying immune system and can also have an effect on the function of other organs in the body. Other R gnavus strains live in the gut lumen (the inside of the large intestine) where they digest any food components that reached the large intestine undigested.

Almost all of the bacteria living in the gut use complex carbohydrates (which come from plant foods, such as fruits, vegetables and legumes) as their main source of food. These provide bacteria with the sugar they need to survive and grow.

But not all of the sugars found in the gut come from the food we eat. Our body can produce its own type of sugars (such as mucin glycans, which make up most of the gut lining). Sugars can also be found covering the surface of bacteria themselves.

While Ruminococcus gnavus can use the sugars found in plant foods for sustenance, some strains have developed a sweet tooth for the sugars found in the gut’s lining. These strains have even evolved selfish survival strategies which ensure they can always access these sugars – regardless of our age, how our diet fluctuates or even when we’re suffering from health problems.

Also, when these sugars are used by R gnavus, the bacteria produce small molecules called metabolites which can then travel to different areas of the body and influence how different organs (such as the brain) function.

While other types of gut bacteria can produce metabolites too, Ruminococcus gnavus is shown to produce certain metabolites that are unique to it. For example, one of the metabolites R gnavus produces has been shown to affect digestion. This could explain why people with IBS experience symptoms such as stomach pain and discomfort.

Finally, sugars coating R gnavus can differ depending on the strain. On some occasions, these may generate an inflammatory response (which means the body’s immune system is primed to attack) as seen in the case of inflammatory bowel disease (IBD).

But some studies done in mice have shown some strains of R gnavus may actually have a protective effect against colitis or atopic eczema for example.

This illustrates the complex relationship Ruminococcus gnavus has when it comes to our health.

This article is part of Meet Your Gut Microbes, a series about the rich constellation of bacteria, viruses, archaea and fungi that live in people’s digestive tracts. Scientists are increasingly realising their importance in shaping our health – both physical and mental. Each week we will look at a different microbe and bring you the most up-to-date research on them.

Nathalie Juge, Deputy Chief Scientific Officer and Group Leader, Glycobiology of Host-Microbe Interactions in the Gut, Quadram Institute

This article is republished from The Conversation under a Creative Commons license. Read the original article.